Mycal Casey, DO, MPH, (@mycalcasey) 's Twitter Profile
Mycal Casey, DO, MPH,

@mycalcasey

Hem/Onc fellow @GeorgetownHOF🩸🦀 #SpartanDO📚#MSUPublicHealth @MCG_InternalMed👨🏻‍⚕️ Interested in Myeloid Malignancies #leusm and Transplant #bmtsm

ID: 1470815834335494148

calendar_today14-12-2021 18:00:06

359 Tweet

218 Takipçi

139 Takip Edilen

Mycal Casey, DO, MPH, (@mycalcasey) 's Twitter Profile Photo

‘Schedule send’ emails is the biggest game changer. Obviously, you can’t choose 8am on the dot. 8:37am, allow them to get that cup of coffee in, and morning meeting out of the way.

Mycal Casey, DO, MPH, (@mycalcasey) 's Twitter Profile Photo

AQUILA: Only 18% of control arm received Dara. The CI for this was 0.27 to 0.98 It’s hard to believe there would OS benefit in 2024,when most patients have Dara with tx. Also unlikely to be statistical significance if there was more crossover. Not to mention other limitations

Mycal Casey, DO, MPH, (@mycalcasey) 's Twitter Profile Photo

I need a drug company to have a clinical trial theme with espresso drinks. Latte-2, cappuccino-1, etc. Then during medical decision making we can say “based on Cortado-5…”